Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

oneKNEE - Prospective, Non-interventional, Multicenter PMCF-Study (oneKNEE)

12 de agosto de 2026 actualizado por: Aesculap AG

oneKNEE - Prospective, Non-interventional, Multicenter Post-Market Clinical Follow-Up Study

Safety and Clinical Performance in terms of clinical outcome of oneKNEE® (total knee arthroplasty TKA), evaluated 2 years after implantation.

Descripción general del estudio

Estado

Aún no reclutando

Condiciones

Intervención / Tratamiento

Descripción detallada

Safety and Clinical Performance will be observed:

Safety: All adverse device effects: serious and non-serious adverse events with relation to either the product or the surgical procedure.

Clinical Performance: Difference in Oxford Knee Score (OKS) 2 years after implantation compared to preoperative state.

Tipo de estudio

De observación

Inscripción (Estimado)

1020

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Heike Oberascher
  • Número de teléfono: +49 7461 95
  • Correo electrónico: studies@aesculap.de

Copia de seguridad de contactos de estudio

  • Nombre: Stefan Maenz, Dr.
  • Número de teléfono: +49 7461 95
  • Correo electrónico: studies@aesculap.de

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

No

Método de muestreo

Muestra no probabilística

Población de estudio

Patients receiving a total knee prosthesis

Descripción

Inclusion Criteria:

  • Patient age ≤ 80 years
  • Indication for a total knee replacement with one of the variants
  • Written informed consent
  • Willingness and mental ability to participate at the long-term follow-up examinations

Exclusion Criteria:

  • Contraindications acc. to the Instructions for Use (IFU)
  • Patient age < 18 years
  • Known pregnancy
  • BMI > 40
  • Secondary gonarthrosis (e.g. rheumatoid arthritis, post-traumatic)
  • Patients classified as high risk (ASA class >3)
  • Patients with immunodeficiency, i.e. patients currently receiving immunosuppressive therapy or patients with severe immunodeficiency requiring drug therapy
  • Preoperative: aHKA > 190° or aHKA < 170°
  • Preoperative: aHKA > 190° or aHKA < 170°[KB1.1][HO1.2][KB1.3][HO1.4]
  • Patients held in a custodial setting und - Patients in a relationship of dependence on the sponsor, the clinic or the investigator

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Safety of the implant
Periodo de tiempo: 2 years after implantation
Safety in terms of clinical outcome of oneKNEE® All adverse device effects: serious and non-serious adverse events with relation to either the product or the surgical procedure.
2 years after implantation
Clinical Performance in terms of clinical outcome of oneKNEE®
Periodo de tiempo: 2 years after implantation

Clinical Performance in terms of clinical outcome of oneKNEE®. Difference in Oxford Knee Score (OKS) 2 years after implantation compared to preoperative state.

The Oxford Knee Score (OKS) is a validated joint-specific patient-reported outcome measure that is commonly employed to assess the outcome of TKA. It is a 12-item, patient-reported questionnaire originally developed and validated specifically to assess function and pain in patients undergoing TKA. It is short, reproducible, valid and sensitive to clinically important changes over time. OKS ranges from 0 to 48 with 48 being the best outcome.

2 years after implantation

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Intraoperative complications
Periodo de tiempo: day of surgery
day of surgery
Optional: OrthoPilot® Data
Periodo de tiempo: Day of surgery
During surgery all data measured and stored by OrthoPilot® the computer assistant (e.g. time needed for the surgery, alignment of all implant components) will be evaluated.
Day of surgery
Clinical Outcome by evaluating the Oxford Knee Score
Periodo de tiempo: V4=3 months post OP, V5= 1year p.OP, V6= 2years p.OP, V7= 5years p.OP
The Oxford Knee Score, OKS is a validated joint-specific patient-reported outcome measure that is commonly employed to assess the outcome of TKA. It is a 12-item, patient-reported questionnaire originally developed and validated specifically to assess function and pain in patients undergoing TKA. It is short, reproducible, valid and sensitive to clinically important changes over time. OKS ranges from 0 to 48 with 48 being the best outcome.
V4=3 months post OP, V5= 1year p.OP, V6= 2years p.OP, V7= 5years p.OP
Evaluation of Changes in Quality of Life
Periodo de tiempo: V1= pre OP, V3= Discharge, V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP,

The EQ-5D-5L is a standardized instrument used to measure health outcomes. Developed by the EuroQol Group (EQ), it assesses five dimensions (5D) of health:

Mobility Self-care Usual activities Pain/discomfort Anxiety/depression Each dimension has five levels (5L) of severity: no problems, slight problems, moderate problems, severe problems, and extreme problems

V1= pre OP, V3= Discharge, V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP,
Evaluation of Patient Satisfaction by using PROMS: FJS
Periodo de tiempo: V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP

Forgotten Joint Score (FJS) : A joint-specific questionnaire with the aim to measure PRO of joint disorders . FJS is designed to measure the ability of the patient to "forget" about their problematic joint after treatment. Scale:

  • 12 questions (How often are you aware of your affected knee joint in everyday life?)
  • 5-point response scale (0-4)
  • responses are then summed and divided by the number of completed items
  • mean value is then multiplied by 25 to obtain the total score of 0-100. A higher score indicates that the patient is less aware of their joint, suggesting better surgical outcomes and higher levels of patient satisfaction.
V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
Knee functional outcome
Periodo de tiempo: V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
Range of Motion (ROM)
V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
Knee alignment, measurement of LDFA: Lateral distal femoral angle
Periodo de tiempo: V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
LDFA: Lateral distal femoral angle. The angle between the mechanical axis of the femur and the knee joint line. Normal values typically range between 85° and 90° Medial proximal tibial angle (MPTA) and lateral distal femoral angle.
V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
Knee alignment, measurement of MPTA: Medial proximal tibial angle
Periodo de tiempo: V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
MPTA: Medial proximal tibial angle. The angle between the mechanical axis of the tibia and the knee joint line. Normal values also typically average around 87° ± 3°.
V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
Knee alignment, measurement of HKA: Hip Knee Angle
Periodo de tiempo: V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
HKA: (Hip Knee Angle). The mechanical angle between the center of the femoral head, the center of the knee, and the center of the ankle. It represents the overall lower limb alignment (e.g., neutral, varus, or valgus)
V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
Radiologically relevant findings by using AI
Periodo de tiempo: V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
"Image biopsy lab" is a Digital AI platform that supports physicians and healthcare professionals in transforming medical imaging data into diagnostic findings.
V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
Adverse events
Periodo de tiempo: until end of study, up to 5 years.
Serious and non-serious adverse events (SAE/AE)
until end of study, up to 5 years.
Device deficiencies assessed by Adverse Events
Periodo de tiempo: until end of study, up to 5 years
In any case of Adverse Events marked as "related to the product/device"
until end of study, up to 5 years
Survival of implant components
Periodo de tiempo: From V3=Discharge to V7= 5 years post OP
From V3=Discharge to V7= 5 years post OP
Anterior knee pain
Periodo de tiempo: V1= preoperatively, V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP,

Anterior knee pain is used to evaluate the performance of the implantation and the implant itself. Rating is classified according to the description of Waters and Bentley in four dimensions: 0 (no pain), I (Mild pain that does not intrude on daily activities), II (Moderate pain that is a nuisance; patient not considering further surgery), III (Severe pain; Patient considering further surgery). The scoring is according to Feller et al. 0, 5, 10 and 15 points, respectively.

(Feller et al., J Bone Joint Surg Am. 2003 Feb;85(2):212-7).

V1= preoperatively, V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP,

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Investigadores

  • Investigador principal: Anne Postler, PD Dr. med, Städt. Klinikum Dresden

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

1 de abril de 2027

Finalización primaria (Estimado)

1 de abril de 2030

Finalización del estudio (Estimado)

1 de diciembre de 2031

Fechas de registro del estudio

Enviado por primera vez

18 de junio de 2026

Primero enviado que cumplió con los criterios de control de calidad

1 de julio de 2026

Publicado por primera vez (Actual)

6 de julio de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

14 de agosto de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

12 de agosto de 2026

Última verificación

1 de agosto de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • AAG-O-H-25103

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .